Highlights for Today
Market Outlook for the day – Our bias is in favor of the bulls, but 6265 will be crucial hurdle to cross on a closing basis.
Credit Analysis and Research (CARE) fell 3.32% on BSE, extending recent losses triggered by IDBI Bank and four other shareholders not finding suitable bids for selling their stakes in the company.
Lupin has received final approval for its Rifabutin Capsules USP, 150 mg from USFDA to market a generic version of Pharmacia and Upjohn Company's Mycobutin Capsules 150 mg.
BHEL won a contract worth Rs 321 crore for setting up a 206 megawatts hydroelectric project in Punjab.
Persistent foreign capital inflows pushed Key benchmark indices positive at the end of the session. Intraday volatility high as traders rolled over positions in the futures and options (F&O) segment from the February 2014 series to March 2014 series. Among IT shares, Infosys and HCL Technologies scaled record high. Buying support witnessed in FMCG and Capital goods segment while Metal stocks closed negative. The market breadth, indicating the overall health of the market, was positive.